|
1
|
Chen Z, Sun H, Yan Y, Wang Y, Zhu C, Zhou
W, Huang L, Wang M, Mize M, Tian J and Ji W: Epidemiological
profiles of hand, foot, and mouth disease, including meteorological
factors, in Suzhou, China. Arch Virol. 160:315–321. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li L, Yin H, An Z and Feng Z:
Considerations for developing an immunization strategy with
enterovirus 71 vaccine. Vaccine. 33:1107–1112. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li H, Li S, Zheng J, Cai C, Ye B, Yang J
and Chen Z: Cerebrospinal fluid Th1/Th2 cytokine profiles in
children with enterovirus 71-associated meningoencephalitis.
Microbiol Immunol. 59:152–159. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ang LW, Tay J, Phoon MC, Hsu JP, Cutter J,
James L, Goh KT and Chow VT: Seroepidemiology of coxsackievirus a6,
coxsackievirus a16, and enterovirus 71 infections among children
and adolescents in Singapore, 2008-2010. PLoS One.
10(e0127999)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Huang X, Wei H, Wu S, Du Y, Liu L, Su J,
Xu Y, Wang H, Li X, Wang Y, et al: Epidemiological and etiological
characteristics of hand, foot, and mouth disease in Henan, China,
2008-2013. Sci Rep. 5(8904)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhou SL, Ying XL, Han X, Sun XX, Jin Q and
Yang F: Characterization of the enterovirus 71 VP1 protein as a
vaccine candidate. J Med Virol. 87:256–262. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang S, Wang Y and Gao H: Research
progress in laboratory detection of common pathogens of hand foot
and mouth disease. J Kunming Med University. 37:1–4. 2016.
|
|
8
|
Ministry of health of the People's
Republic of China. Hand-foot-mouth disease prevention and control
guidelines (2008 edition). Capital Public Health. 2:146–148.
2008.
|
|
9
|
Zhiqin Zhang and Guoshi Xiang: Research
progress of enterovirus 71 VP1 protein. Chin J Zoonoses.
31:377–379, 390. 2015.
|
|
10
|
Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M
and Liang Z: Coxsackievirus A16: Epidemiology, diagnosis, and
vaccine. Hum Vaccin Immunother. 10:360–367. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Yao X, Bian LL, Mao QY, Zhu FC, Ye Q and
Liang ZL: Echovirus 7 associated with hand, foot, and mouth disease
in mainland China has undergone a recombination event. Arch Virol.
160:1291–1295. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Guoquan Zhang: Observation on the curative
effect of treating HFMD in adults by integrated Chinese and western
medicine. Zhejiang J Integrated Chin Western Med 2014: 825-826.
|
|
13
|
Linghua Yu, Xinguang Yin, Xingju Wang, et
al: Analysis of correlation characteristics of 41 adult hand, foot
and mouth disease patients. Chin J Infectious Dis. 31:560–563.
2013.
|
|
14
|
Chen GP, Wu JB, Wang JJ, Pan HF, Zhang J,
Shi YL, Cao C, Li FR, Fan YG, Meng FY and Ye DQ: Epidemiological
characteristics and influential factors of hand, foot and mouth
disease (HFMD) reinfection in children in Anhui province. Epidemiol
Infect. 144:153–160. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou X, Zhu Q, Xia W, He F, Hu M, Ni X,
Gao M, Chen H and Chen S: Molecular epidemiology of an outbreak of
hand, foot, and mouth disease associated with subgenotype C4a of
enterovirus A71 in Nanchang, China in 2014. J Med Virol.
87:2154–2158. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Eshima N, Tokumaru O, Hara S, Bacal K,
Korematsu S, Karukaya S, Uruma K, Okabe N and Matsuishi T:
Age-specific sex-related differences in infections: A statistical
analysis of national surveillance data in Japan. PLoS One.
7(e42261)2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jianbo Wang, Yan Li, Xiaohong Li, et al:
Four cases of hand foot and mouth disease in adults and virological
observation. Chin J Dermatol. 47:659–660. 2014.
|
|
18
|
Yubao Lian and Jinqiu Yu: A case of adult
severe hand, foot and mouth disease. Chin J Clin Infect Dis. 3:376.
2010.
|
|
19
|
Sheng Zhang, Lingjia Li, Hui Gao, et al:
Clinical report of 2 adult cases of hand foot and mouth disease and
its family pathogen aggregation. Lab Med. 31:733–734. 2016.
|
|
20
|
Mingyu Xie, Qi Peng, Xiaomei Lu, et al:
Research progress on human enterovirus 71 vaccine. Chin J Clin
Pediatrics. 31:1508–1512. 2016.
|
|
21
|
Kataoka C, Suzuki T, Kotani O,
Iwata-Yoshikawa N, Nagata N, Ami Y, Wakita T, Nishimura Y and
Shimizu H: The role of VP1 amino acid residue 145 of enterovirus 71
in viral fitness and pathogenesis in a cynomolgus monkey model.
PLoS Pathog. 11(e1005033)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zongmin Fu, Xiaoling Xia, Lin Zhao, Ping
Zhao and Ling Zhao: Pathogen detection and clinical characteristics
analysis of hand, foot and mouth disease in kunming in 2011. J Clin
Pediatrics. 31:48–51. 2013.
|
|
23
|
Sanders SA, Herrero LJ, McPhie K, Chow SS,
Craig ME, Dwyer DE, Rawlinson W and McMinn PC: Molecular
epidemiology of enterovirus 71 over two decades in an Australian
urban community. Arch Virol. 151:1003–1013. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wenxiang He, Yongjun Zhang, Guangmin Chen,
Ying Zhu, Wei Chen and Yuwei Weng: Analysis of prevalence and
genetic variation of EV71 in fujian province. Chin J Zoonoses.
33:136–142. 2017.
|
|
25
|
Li YX, Zhao H, Cao RY, Deng YQ, Han JF,
Zhu SY, Ma J, Liu L, Qin ED and Qin CF: Recombinant tandem
multi-linear neutralizing epitopes of human enterovirus 71 elicited
protective immunity in mice. Virol J. 11(79)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nishimura Y, Lee H, Hafenstein S, Kataoka
C, Wakita T, Bergelson JM and Shimizu H: Enterovirus 71 Binding to
PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control
Receptor Interaction. PLoS Pathog. 9(e1003511)2013.PubMed/NCBI View Article : Google Scholar
|
